Novel cardiovascular therapeutics and the risk of financial toxicity

Nat Rev Cardiol. 2024 Jun;21(6):349-350. doi: 10.1038/s41569-024-01010-4.
No abstract available

MeSH terms

  • Cardiovascular Agents* / adverse effects
  • Cardiovascular Agents* / economics
  • Cardiovascular Agents* / therapeutic use
  • Cardiovascular Diseases* / economics
  • Drug Costs
  • Humans

Substances

  • Cardiovascular Agents